12/18/20

Obatala Receives Ochsner Health Funding

Obatala Sciences, Receives Investment from Healthcare Innovation Fund II This update is based on an article by Anthony Mcauley, published yesterday on nola.com:  Obatala Sciences, a NOBIC client company that…


12/04/20

BioFund Portfolio Company, BIoAesthetics, Lands University Clinical Study

BioAesthetics Announces University Clinical Study for its Nipple Reconstruction Graft NACgraft Aims to Improve Quality-of-Life for Breast Cancer Patients   RESEARCH TRIANGLE PARK, NC. (Dec. 3, 2020) —  BioAesthetics Corporation yesterday…


11/16/20

NOBIC Client Chosen Diagnostics’ Device Authorized as Breakthrough

Chosen Diagnostics’ NECDetect for Preterm Babies Authorized as Breakthrough Device by FDA NEW ORLEANS, LA. (Nov. 16, 2020) — Chosen Diagnostics is pleased to announce that the US Food &…


11/02/20

NOBIC Tenant AxoSim Awarded $870K in Federal Funding

PRESS RELEASE: AxoSim Announces the Award of Over $870K in Federal Grants   Overview –Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health…


09/09/20

PRESS RELEASE: ReactWell Receives U.S. Department of Energy Funding

Louisiana Company Receives U.S. Department of Energy Funding LTTO Client Secures Award to Advance an Integrated Carbon Dioxide Capture and Conversion to Ethanol Technology A Louisiana Technology Transfer Office (LTTO)…


03/13/19

ReactWell Licenses ORNL Catalyst for Energy Conversion Applications

ReactWell, a NOBIC client and tenant, recently announced a partnership with Oak Ridge National Lab. The Company has licensed a novel waste-to-fuel technology to improve energy conversion methods for cleaner,…


03/13/19

CADEX Genomics Launches Clinical Study

Cadex Genomics, a newly funded company based on technology developed in Louisiana, recently announced the launch of a clinical study at Rocky Mountain Cancer Center. The company had recently raised…


01/17/19

BARDA Announces Interagency Group to Battle Opioid Epidemic

The Biomedical Advanced Research and Development Authority (BARDA) is leading an interagency group to develop a wearable device to detect, and possibly treat, an opioid overdose.  This group, Technology Innovation…


11/18/18

Gremillion Technologies Wins BioChallenge and BioFund Prizes

Local physician and entrepreneur Grayson Gremillion presented his company at the 7th annual BioChallenge pitch competition at the Joy Theater on November 14, and was selected as the winner of…